Logo image of SOLB.BR

SOLVAY SA (SOLB.BR) Stock Fundamental Analysis

EBR:SOLB - BE0003470755 - Common Stock

27.48 EUR
+0.18 (+0.66%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

5

SOLB gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 68 industry peers in the Chemicals industry. SOLB has a medium profitability rating, but doesn't score so well on its financial health evaluation. SOLB has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

SOLB had positive earnings in the past year.
SOLB had a positive operating cash flow in the past year.
SOLB had positive earnings in 4 of the past 5 years.
SOLB had a positive operating cash flow in each of the past 5 years.
SOLB.BR Yearly Net Income VS EBIT VS OCF VS FCFSOLB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

SOLB's Return On Assets of 2.21% is fine compared to the rest of the industry. SOLB outperforms 60.29% of its industry peers.
SOLB has a better Return On Equity (12.19%) than 75.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 8.43%, SOLB is in the better half of the industry, outperforming 72.06% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SOLB is above the industry average of 7.11%.
Industry RankSector Rank
ROA 2.21%
ROE 12.19%
ROIC 8.43%
ROA(3y)13.55%
ROA(5y)7.71%
ROE(3y)64.09%
ROE(5y)37.45%
ROIC(3y)11.19%
ROIC(5y)8.96%
SOLB.BR Yearly ROA, ROE, ROICSOLB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

SOLB's Profit Margin of 2.81% is in line compared to the rest of the industry. SOLB outperforms 58.82% of its industry peers.
SOLB's Profit Margin has improved in the last couple of years.
SOLB has a better Operating Margin (10.64%) than 75.00% of its industry peers.
SOLB's Operating Margin has improved in the last couple of years.
SOLB has a Gross Margin of 21.23%. This is in the lower half of the industry: SOLB underperforms 69.12% of its industry peers.
SOLB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.64%
PM (TTM) 2.81%
GM 21.23%
OM growth 3Y5%
OM growth 5Y4.03%
PM growth 3Y-17.12%
PM growth 5Y176.86%
GM growth 3Y-4.43%
GM growth 5Y-3.41%
SOLB.BR Yearly Profit, Operating, Gross MarginsSOLB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SOLB is creating value.
SOLB has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, SOLB has more shares outstanding
Compared to 1 year ago, SOLB has a worse debt to assets ratio.
SOLB.BR Yearly Shares OutstandingSOLB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SOLB.BR Yearly Total Debt VS Total AssetsSOLB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

SOLB has an Altman-Z score of 1.87. This is not the best score and indicates that SOLB is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.87, SOLB is not doing good in the industry: 63.24% of the companies in the same industry are doing better.
SOLB has a debt to FCF ratio of 9.16. This is a negative value and a sign of low solvency as SOLB would need 9.16 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 9.16, SOLB is doing good in the industry, outperforming 63.24% of the companies in the same industry.
SOLB has a Debt/Equity ratio of 1.80. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of SOLB (1.80) is worse than 89.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 9.16
Altman-Z 1.87
ROIC/WACC1.38
WACC6.09%
SOLB.BR Yearly LT Debt VS Equity VS FCFSOLB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

SOLB has a Current Ratio of 1.33. This is a normal value and indicates that SOLB is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.33, SOLB is doing worse than 76.47% of the companies in the same industry.
SOLB has a Quick Ratio of 1.33. This is a bad value and indicates that SOLB is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.96, SOLB is doing worse than 61.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.96
SOLB.BR Yearly Current Assets VS Current LiabilitesSOLB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2

3. Growth

3.1 Past

SOLB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -94.29%.
Measured over the past years, SOLB shows a very strong growth in Earnings Per Share. The EPS has been growing by 153.72% on average per year.
Looking at the last year, SOLB shows a very negative growth in Revenue. The Revenue has decreased by -57.61% in the last year.
Measured over the past years, SOLB shows a very negative growth in Revenue. The Revenue has been decreasing by -14.50% on average per year.
EPS 1Y (TTM)-94.29%
EPS 3Y-37%
EPS 5Y153.72%
EPS Q2Q%-11.54%
Revenue 1Y (TTM)-57.61%
Revenue growth 3Y-23.45%
Revenue growth 5Y-14.5%
Sales Q2Q%-7.71%

3.2 Future

SOLB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.95% yearly.
Based on estimates for the next years, SOLB will show a decrease in Revenue. The Revenue will decrease by -0.04% on average per year.
EPS Next Y-18.61%
EPS Next 2Y-7.07%
EPS Next 3Y-0.64%
EPS Next 5Y1.95%
Revenue Next Year-7.57%
Revenue Next 2Y-1.47%
Revenue Next 3Y-0.01%
Revenue Next 5Y-0.04%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SOLB.BR Yearly Revenue VS EstimatesSOLB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B
SOLB.BR Yearly EPS VS EstimatesSOLB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.21 indicates a rather cheap valuation of SOLB.
SOLB's Price/Earnings ratio is rather cheap when compared to the industry. SOLB is cheaper than 97.06% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.06, SOLB is valued rather cheaply.
With a Price/Forward Earnings ratio of 7.78, the valuation of SOLB can be described as very cheap.
Based on the Price/Forward Earnings ratio, SOLB is valued cheaply inside the industry as 98.53% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of SOLB to the average of the S&P500 Index (22.69), we can say SOLB is valued rather cheaply.
Industry RankSector Rank
PE 7.21
Fwd PE 7.78
SOLB.BR Price Earnings VS Forward Price EarningsSOLB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

86.76% of the companies in the same industry are more expensive than SOLB, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, SOLB is valued cheaply inside the industry as 85.29% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.97
EV/EBITDA 5.45
SOLB.BR Per share dataSOLB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The decent profitability rating of SOLB may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.05
EPS Next 2Y-7.07%
EPS Next 3Y-0.64%

5

5. Dividend

5.1 Amount

SOLB has a Yearly Dividend Yield of 6.04%, which is a nice return.
SOLB's Dividend Yield is rather good when compared to the industry average which is at 3.08. SOLB pays more dividend than 94.12% of the companies in the same industry.
SOLB's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 6.04%

5.2 History

The dividend of SOLB decreases each year by -9.94%.
Dividend Growth(5Y)-9.94%
Div Incr Years3
Div Non Decr Years4
SOLB.BR Yearly Dividends per shareSOLB.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

182.73% of the earnings are spent on dividend by SOLB. This is not a sustainable payout ratio.
DP182.73%
EPS Next 2Y-7.07%
EPS Next 3Y-0.64%
SOLB.BR Yearly Income VS Free CF VS DividendSOLB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B
SOLB.BR Dividend Payout.SOLB.BR Dividend Payout, showing the Payout Ratio.SOLB.BR Dividend Payout.PayoutRetained Earnings

SOLVAY SA

EBR:SOLB (9/5/2025, 7:00:00 PM)

27.48

+0.18 (+0.66%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners26.72%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.91B
Analysts68.7
Price Target30.97 (12.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.04%
Yearly Dividend2.44
Dividend Growth(5Y)-9.94%
DP182.73%
Div Incr Years3
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.02%
Min EPS beat(2)9%
Max EPS beat(2)11.03%
EPS beat(4)3
Avg EPS beat(4)10.23%
Min EPS beat(4)-1.96%
Max EPS beat(4)22.86%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.62%
Min Revenue beat(2)-4.75%
Max Revenue beat(2)-2.48%
Revenue beat(4)0
Avg Revenue beat(4)-2.86%
Min Revenue beat(4)-4.75%
Max Revenue beat(4)-0.96%
Revenue beat(8)2
Avg Revenue beat(8)-1.68%
Revenue beat(12)6
Avg Revenue beat(12)4.24%
Revenue beat(16)10
Avg Revenue beat(16)9.1%
PT rev (1m)-5.4%
PT rev (3m)-10.85%
EPS NQ rev (1m)-13.92%
EPS NQ rev (3m)-19.05%
EPS NY rev (1m)-18.17%
EPS NY rev (3m)-18.17%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.81%
Revenue NY rev (3m)-8.76%
Valuation
Industry RankSector Rank
PE 7.21
Fwd PE 7.78
P/S 0.59
P/FCF 11.97
P/OCF 5.28
P/B 2.55
P/tB 17.74
EV/EBITDA 5.45
EPS(TTM)3.81
EY13.86%
EPS(NY)3.53
Fwd EY12.85%
FCF(TTM)2.3
FCFY8.35%
OCF(TTM)5.2
OCFY18.94%
SpS46.8
BVpS10.77
TBVpS1.55
PEG (NY)N/A
PEG (5Y)0.05
Profitability
Industry RankSector Rank
ROA 2.21%
ROE 12.19%
ROCE 11.24%
ROIC 8.43%
ROICexc 9.07%
ROICexgc 11.69%
OM 10.64%
PM (TTM) 2.81%
GM 21.23%
FCFM 4.9%
ROA(3y)13.55%
ROA(5y)7.71%
ROE(3y)64.09%
ROE(5y)37.45%
ROIC(3y)11.19%
ROIC(5y)8.96%
ROICexc(3y)12.43%
ROICexc(5y)9.87%
ROICexgc(3y)17.2%
ROICexgc(5y)14.4%
ROCE(3y)14.91%
ROCE(5y)11.94%
ROICexcg growth 3Y8.77%
ROICexcg growth 5Y9.63%
ROICexc growth 3Y18.23%
ROICexc growth 5Y16.44%
OM growth 3Y5%
OM growth 5Y4.03%
PM growth 3Y-17.12%
PM growth 5Y176.86%
GM growth 3Y-4.43%
GM growth 5Y-3.41%
F-Score4
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 9.16
Debt/EBITDA 2.33
Cap/Depr 87.75%
Cap/Sales 6.22%
Interest Coverage 7.75
Cash Conversion 62.76%
Profit Quality 174.82%
Current Ratio 1.33
Quick Ratio 0.96
Altman-Z 1.87
F-Score4
WACC6.09%
ROIC/WACC1.38
Cap/Depr(3y)94.75%
Cap/Depr(5y)76.26%
Cap/Sales(3y)9.62%
Cap/Sales(5y)7.99%
Profit Quality(3y)83.5%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-94.29%
EPS 3Y-37%
EPS 5Y153.72%
EPS Q2Q%-11.54%
EPS Next Y-18.61%
EPS Next 2Y-7.07%
EPS Next 3Y-0.64%
EPS Next 5Y1.95%
Revenue 1Y (TTM)-57.61%
Revenue growth 3Y-23.45%
Revenue growth 5Y-14.5%
Sales Q2Q%-7.71%
Revenue Next Year-7.57%
Revenue Next 2Y-1.47%
Revenue Next 3Y-0.01%
Revenue Next 5Y-0.04%
EBIT growth 1Y-67.31%
EBIT growth 3Y-19.61%
EBIT growth 5Y-11.06%
EBIT Next Year39.83%
EBIT Next 3Y15.32%
EBIT Next 5Y8.95%
FCF growth 1Y-79.37%
FCF growth 3Y-27.42%
FCF growth 5Y-19.2%
OCF growth 1Y-75.53%
OCF growth 3Y-25.69%
OCF growth 5Y-19.46%